Cancer survivors, complications. Warning: Exposed to endocrine problems, osteoporosis or diabetes

Common endocrine complications include hypothalamic-pituitary dysfunction, hypogonadism, osteoporosis, metabolic disorders, and vitamin D deficiency. These conditions can lead to comorbidities such as obesity, diabetes, and cardiovascular complications.

Specific populations, such as those receiving endocrine therapy for breast or prostate cancer, tyrosine kinase inhibitors, or immune checkpoint inhibitors, present unique risks and require tailored management strategies.

Early detection and intervention are crucial to the management of endocrine complications in cancer survivors. Collaboration between oncologists and endocrinologists, standardized screening tools and clear treatment algorithms are essential to optimize care and improve outcomes in this growing population, according to a study published in The Lancet.

Cancer survivors, complications

Patients who have successfully gone through cancer, or who have their cancer under control for the long term, may experience endocrine problems, such as hormone disturbances, osteoporosis, or metabolic problems. These complications can range from mild symptoms to profoundly affecting quality of life.

More cancer survivors are facing these issues as their numbers are increasing. Endocrine problems may affect between 40% and 60% of them, including thyroid gland, hormonal and metabolic disorders. The causes are diverse, and the risk differs from one patient to another, being influenced by the type of cancer and the treatment received.

See also: The link between anxiety and feeling sick. Radu Leca: If we turned anxiety into a power, then the anxious would be a world champion at everything

Cancer survivors – PHOTO: Freepik@Phalow

To manage these complications, it is important to be aware of them and have regular tests to detect them in time. Endocrinologists and oncologists must work together to identify patients at risk and provide them with appropriate treatment.

Comorbidities are common among cancer survivors and may include metabolic disorders such as diabetes and obesity. Cancer treatment itself can contribute to these problems, increasing the risk of obesity or hormonal disorders.

See also: Disease that has disastrous consequences. Prof. Dr. Sebastian Cozma: It is worrying

Patients receiving treatment with tyrosine kinase inhibitors or immune checkpoint inhibitors may also have endocrine complications such as thyroid disorders or adrenal insufficiency. Careful monitoring and appropriate treatment are essential for these patients.

Secondary hyperparathyroidism is another problem encountered, especially in patients with chronic renal failure or those on dialysis. This condition can affect bones and increase the risk of cardiovascular complications.

In conclusion, cancer survivors require special attention regarding their endocrine and metabolic health, and appropriate management of these complications can improve their quality of life and long-term prognosis.

Stay up to date with the latest news. Follow DCMedical on Google News as well

Did this article help you?

Follow the DCMedical Facebook page and the DCMedical Health Dose Instagram page and access more useful content for your health, disease prevention and treatment, first aid measures and useful advice from doctors and patients.